Cancer Australia

Cancer Australia is calling for applications for the Partnerships for Cancer Research grant program – a new $9.6 million initiative to support cancer research for and by Aboriginal and Torres Strait Islander people. Cancer Australia is delivering this grant in partnership with the National Health and Medical Research Council (NHMRC). This national grant program aims to involve communities in designing research for their benefit and strengthen partnerships between communities, health services, and research institutions. Partnerships, with funding of up to $2.5 million each, will improve outcomes for Aboriginal and Torres Strait Islander people, enhance equitable cancer care, build research skills among Aboriginal and Torres Strait Islander researchers, and support local leadership in cancer research.  Applications for the Partnerships for Cancer Research grant program are currently being accepted until 5pm (AEDT) Wednesday 12 February 2025, via NHMRC's grant management system – Sapphire. To learn more about the Partnerships for Cancer Research grant program and how to submit an application, visit https://bit.ly/4cEY7lw

Have your say on the draft National Cancer Data Framework! The Data Framework will set the strategic direction and priorities for the collection, management, use and ongoing development of data to improve cancer outcomes. It will align with existing and planned national health data initiatives, including the ambitions set out in the Australian Cancer Plan. This is your chance to contribute and help shape this important work. Visit the Engagement Hub to view the draft Data Framework complete the online survey: https://bit.ly/4foO1q0 Consultation will close 19 November 2024.

Congratulations to the grant recipients for the 2024-2027 Support for Cancer Clinical Trials (SCCT) program, with a total of $22.2 million awarded over the next three years. This funding, administered by Cancer Australia, will support 14 Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) across the country. The SCCT program is globally unique, designed specifically to fund the development of clinical trial protocols and build sector capacity through core infrastructure funding. The program fills a critical research funding gap in Australia by supporting the advancement of cancer prevention, treatment, and care programs that may not attract commercial interest from industry. The 14 CTGs include: GI Cancer Institute & Australasian Gastro-Intestinal Trials Group, Australasian Leukaemia & Lymphoma Group (ALLG), ANZCHOG, Australia New Zealand Gynaecological Oncology Group (ANZGOG), Australia and New Zealand Sarcoma Association, ANZUP Cancer Trials Group Limited, Breast Cancer Trials, COGNO - Cooperative Trials Group for Neuro-Oncology, Cancer Symptom Trials, Melanoma and Skin Cancer Trials, PC4 - Primary Care Collaborative Cancer Clinical Trials Group, Psycho-oncology Co-operative Research Group, Thoracic Oncology Group of Australasia, and Trans Tasman Radiation Oncology Group (TROG Cancer Research). https://bit.ly/4ewNdza

Closing soon! Be sure to submit your application for the Partnerships for culturally safe cancer care grant program by 23 October. To learn more about the grant, eligibility and how to apply, visit https://bit.ly/4cEY7lw

The Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer (2nd Ed) aims to reduce disparities in cancer outcomes by addressing specific needs and challenges of First Nations people and ensuring competent and culturally safe care https://bit.ly/4egQanE

The new National Optimal Care Pathways (OCPs) Framework standardises the development, update, evaluation and uptake of OCPs to support a consistent approach to OCPs across heath services and jurisdictions. Learn more and download your copy today: https://bit.ly/4egQanE

Cancer Australia is calling for applications for the Partnerships for culturally safe cancer care grant program - a new initiative aimed at accelerating the delivery of culturally safe cancer care for Aboriginal and Torres Strait Islander communities across Australia. This national grant program will allocate up to $16.9 million over three years to support up to 20 partnerships between cancer services and Aboriginal and/or Torres Strait Islander community-controlled organisations. Partnerships, with funding of up to $1 million each, will focus on innovative, community-driven local activities designed to improve the delivery of cancer care for Aboriginal and Torres Strait Islander people. Applications for the Partnerships for culturally safe cancer care grant program are currently being accepted until 23 October 2024. To learn more about the Partnerships for culturally safe cancer care grant program and how to submit an application, visit https://bit.ly/4cEY7lw

Cancer Australia in partnership with the Aurora Education Foundation is calling for applications for the First Nations Cancer Scholarship - a ground-breaking new scholarship program for Aboriginal and Torres Strait Islander students, health professionals and researchers in the field of cancer. Aboriginal and Torres Strait Islander graduate students, early career researchers and health professionals can apply through Aurora’s Indigenous Pathways Portal for financial support of up to $120,000 annually for up to 3 years, as well as academic, wellbeing and community support. Expressions of Interest for the First Nations Cancer Scholarship are being accepted until 30 August 2024. To learn more about the scholarship program and to submit an application, visit https://bit.ly/4blKqXj

Calling cancer care professionals, researchers, and organisations: Join us at the Australian Comprehensive Cancer Network Innovations Showcase on 21 May in Sydney, and hear about how we can work together to ensure the best cancer care for all patients across Australia, regardless of who they are or where they live. In-person and online spots are available. Register here: https://lnkd.in/gY5Y4zqy 

We’re excited to announce that Professor Dorothy Keefe PSM MD will be one of the keynote speakers at the 2024 Melanoma and Skin Cancer Trials Annual Scientific Meeting on 24 October 2024 in Sydney.   Professor Keefe is CEO of Cancer Australia, a position she has held since 2019. She is a qualified and experienced medical oncologist and an honorary Clinical Professor in the School of Medicine at the University of Adelaide.    Professor Keefe’s keynote address will cover Cancer Australia’s support for Australia’s Multi-site Collaborative Cancer Clinical Trials Groups, including Melanoma and Skin Cancer Trials, insights on the first year of the Australian Cancer Plan, and the importance of clinical trials, research and good data to achieving the objectives of the Plan.   Register 👉 https://lnkd.in/gcMFgt7n   #MelanomaResearch #SkinCancerTrials #AMC2024 #ASM2024 #Melanoma #SkinCancer #Ocularmelanoma #Merkelcellcarcinoma #Clinicaltrials #Clinicalresearch Cancer Australia Dorothy Keefe Mark Shackleton Gabrielle Byars AAICD Michael Kimlin Mary Tsouvalakis Patrick Baker Wen Xu Stephen Nicholls Melanoma Institute Australia Pascale Guitera Alison Button-Sloan Nikolas Haass Kiarash Khosrotehrani Jia (Jenny) Liu Alexander Guminski Anthony Joshua Michelle Taylor Teresa Lee Anne Gately Medison Pharma Bristol Myers Squibb